Paclitaxel immediately following autologous bone marrow transplantation further reduces residual disease in patients with metastatic breast cancer (MBC)

Authors :: Rahman, Z.
Kavanagh, J.
Giles, R.
Hanania, E.
Holmes, F.
Booser, D.
Fu, S.Q.
Zu, Z.
Ellerson, D.
Clavert, L.
Claxton, D.
Bachier, C.
Berenson, R.
Holzmayer, T.
Dayn, A.
Heimfield, S.
Hortobagyi, G.
Bast, R.
Andreeff, M.
Champlin, R.
Deisseroth, A.
Source :: Cancer Weekly Plus. June 30, 1997, Issue 9, p30, 1 p.
Publication Year :: 1997
Abstract: 'Paclitaxel Immediately Following Autologous Bone Marrow Transplantation Further Reduces Residual Disease in Patients with Metastatic Breast Cancer (MBC).' Z. Rahman, J. Kavanagh, R. Giles, E. Hanania, F. Holmes, D. Booser, [...]

Subjects :: Hematopoietic stem cells -- Transplantation
Chemotherapy -- Health aspects
Cancer -- Chemotherapy
Breast cancer -- Health aspects
Paclitaxel -- Health aspects
Health
Health aspects

Tools